Pfizer Begins Spinoff Of Animal Health Business

Law360, New York (June 07, 2012, 2:27 PM ET) -- Pfizer Inc. on Thursday made good on its promise to spin off or sell its animal health business, announcing the formation of a new company, Zoetis, which it will take public by next July.

The move follows the $11.85 billion sale of its infant nutrition unit to Nestle SA in April as the world's biggest drugmaker looks to squeeze more growth from its core biopharmaceutical division. New York-based Pfizer had been exploring options, including spinoffs and sales, for both units since last summer.

It said it...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers